[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-european-commission-cancer-mission-clinical-research-on-lung-bowel-bre-2026":3,"similar-european-commission-cancer-mission-clinical-research-on-lung-bowel-bre-2026":27},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":8,"budget_max_eur":8,"deadline":8,"deadline_note":9,"duration":8,"trl":8,"relevance":8,"why_relevant":8,"early_career":10,"consortium":11,"first_seen":12,"last_updated":8,"update_note":8,"status":13,"stages":8,"call_frequency":8,"next_call_expected":8,"source_url":7,"created_at":14,"updated_at":15,"eligible_countries":8,"description":16,"seo_summary":17,"recurring_round":10,"canonical_id":4,"links":18},"european-commission-cancer-mission-clinical-research-on-lung-bowel-bre-2026","Cancer Mission Clinical Research on Lung, Bowel, Breast or Prostate Cancer","European Commission","https:\u002F\u002Fec.europa.eu\u002Finfo\u002Ffunding-tenders\u002Fopportunities\u002Fportal\u002Fscreen\u002Fopportunities\u002Ftopic-details\u002FHORIZON-MISS-2027-02-CANCER-02",null,"Call identifier HORIZON-MISS-2027-02-CANCER-02; no submission deadline stated on page",false,"Required — minimum 3 entities from 3 EU member states; additionally, comprehensive cancer infrastructures must pilot\u002Fupscale in at least 4 different EU Member States or Associated Countries, including one with limited cancer infrastructure","2026-08-19T00:00:00.000Z","open","2026-08-19T03:56:14.796Z","2026-08-19T05:02:55.107Z","Supports clinical research on lung, bowel, breast or prostate cancer conducted by comprehensive cancer infrastructures across EU Member States and Associated Countries. Covers innovative diagnostics, radiotherapy\u002Fsurgery\u002Fchemotherapy, therapeutic cancer vaccines, and guideline implementation. Requires multi-stakeholder consortia, patient co-design, sex\u002Fgender-disaggregated data, and open science compliance via UNCAN.eu. Successful projects join the EU Cancer Mission 'Diagnosis and Treatment' cluster.","{\"summary\":\"The European Commission's Cancer Mission Clinical Research on Lung, Bowel, Breast or Prostate Cancer funds multi-centre clinical trials and implementation projects led by comprehensive cancer infrastructures across Europe. Projects must build 3+ entity consortia spanning at least 3 EU member states, with pilot or scale-up in at least 4 countries including one with limited cancer infrastructure. The call covers innovative diagnostics, radiotherapy, chemotherapy, surgery, therapeutic vaccines, and guideline implementation, all anchored in patient co-design and open science through the UNCAN.eu platform.\",\"meta_description\":\"Cancer Mission Clinical Research funds EU-wide lung, bowel, breast and prostate cancer trials led by comprehensive cancer infrastructures, 3+ country consortia required, from EC.\",\"who_should_apply\":[\"Comprehensive cancer infrastructure centres or networks with established clinical research capacity\",\"Institutions willing to build consortia of 3+ entities across 3+ EU\u002FAssociated countries\",\"Research teams piloting or scaling innovations in diagnostics, surgery, radiotherapy, chemotherapy or therapeutic vaccines\",\"Centres committing to patient co-design, sex\u002Fgender-disaggregated data collection, and UNCAN.eu open science compliance\",\"Projects addressing underserved regions or countries with limited cancer infrastructure\"],\"key_dates\":[\"Call identifier: HORIZON-MISS-2027-02-CANCER-02 (consult Funding and Tenders portal for submission deadline)\",\"Multi-stage evaluation including consortium feasibility assessment\",\"Successful projects join the EU Cancer Mission 'Diagnosis and Treatment' cluster\"],\"tips\":[\"Consortium governance is non-negotiable, demonstrate clear roles for each of your 3+ partners and name a lead centre; vague 'networks' without formal agreements score poorly.\",\"Patient co-design is mandatory, not optional; include patient representatives in your steering group and describe their involvement in study design and dissemination.\",\"Explicit plans to include a centre in a country with limited cancer infrastructure will differentiate your proposal; do not leave this to chance.\"],\"faq\":[{\"q\":\"What cancers can I apply for under the Cancer Mission Clinical Research call?\",\"a\":\"The call funds projects on lung, bowel, breast, or prostate cancer conducted by comprehensive cancer infrastructures across EU member states and associated countries.\"},{\"q\":\"How many partners do I need for the Cancer Mission Clinical Research call?\",\"a\":\"A minimum of 3 entities from 3 different EU member states, and your consortium must pilot or scale-up in at least 4 different EU member states or associated countries, including one with limited cancer infrastructure.\"},{\"q\":\"What types of research does the Cancer Mission Clinical Research call fund?\",\"a\":\"Innovative diagnostics, radiotherapy, surgery, chemotherapy, therapeutic cancer vaccines, and guideline implementation, all conducted within comprehensive cancer infrastructure networks.\"},{\"q\":\"Is patient involvement required in the Cancer Mission Clinical Research call?\",\"a\":\"Yes, projects must include patient co-design and collect sex\u002Fgender-disaggregated data as part of the multi-stakeholder approach mandated by the call.\"}],\"tags\":[\"cancer-biology\",\"horizon-europe\",\"clinical-research\",\"consortium-required\",\"translational\",\"eu-wide\",\"cancer-mission\"]}",{"matchedProgram":8,"resourceSlug":19,"relatedGuides":20,"countryHubs":21,"domainHubs":22,"closingMonth":8,"hasRelated":26,"hasBrowseRelated":26},"horizon-europe",[],[],[23],{"slug":24,"name":25},"cancer-biology","Cancer biology",true,{"grants":28},[29,32,37,41,45],{"id":30,"name":31,"funder":6,"deadline":8,"budget":8},"european-commission-capacity-building-programme-for-comprehensive-canc-2026","Capacity-building programme for Comprehensive Cancer Infrastructures",{"id":33,"name":34,"funder":6,"deadline":35,"budget":36},"european-commission-cancer-mission-ria-horizon-miss-2026-02-cancer-02","Cancer Mission Ria – Horizon-Miss-2026-02-Cancer-02","2026-09-15T00:00:00.000Z","Around €15M",{"id":38,"name":39,"funder":6,"deadline":35,"budget":40},"european-commission-cancer-mission-innovation-action-horizon-miss-2026","Cancer Mission Innovation Action – HORIZON-MISS-2026-02-CANCER-05","Around €7M",{"id":42,"name":43,"funder":6,"deadline":35,"budget":44},"european-commission-cancer-mission-coordination-and-support-action-hor-2026-09","Cancer Mission Coordination and Support Action – HORIZON-MISS-2026-02-CANCER-06","Around €5M",{"id":46,"name":47,"funder":6,"deadline":8,"budget":8},"european-commission-microbiome-tools-for-cancer-prevention-and-early-d-2026","Microbiome tools for cancer prevention and early detection"]